Foteini S.
- Country
- Greece
- Department
- Department of Internal Medicine and Autoimmune Diseases
Research Overview
- Efficacy and Safety Evaluation of Efgartigimod Alfa Subcutaneous Injection in Adult Patients with Primary Sjögren’s Disease: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial
- A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants with Primary Sjogren’s Disease with Moderate to Severe Systemic Disease Activity
Data & Insights
Has run more than one trial at 15 of 113 partner sites.
Specializations
Autoimmune Disorders
The investigator specializes in the treatment and research of Primary Sjögren's Disease, an autoimmune condition affecting the body's moisture-producing glands.
- Systemic Disease Management
- Novel Therapeutic Approaches
- Autoimmune Disease Assessment
Their clinical focus encompasses comprehensive evaluation of systemic disease activity and exploration of innovative treatment modalities for autoimmune conditions.
Clinical Assessment
The investigator's expertise includes the evaluation of disease activity measurements and patient outcomes in autoimmune disorders.
- Disease Activity Monitoring
- Clinical Efficacy Assessment
- Patient Safety Evaluation
Their work involves detailed assessment of therapeutic interventions and their impact on systemic disease manifestations.
Therapeutic Innovation
The investigator focuses on advancing treatment options for autoimmune disorders through evaluation of novel therapeutic agents.
- Immunological Interventions
- Treatment Safety Profiles
- Therapeutic Response Assessment
Their research interests include investigating new treatment approaches for managing autoimmune conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.